Daniel Clark
Stock Analyst at Leerink Partners
(2.12)
# 2,804
Out of 4,876 analysts
4
Total ratings
66.67%
Success rate
4.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintains: Outperform | $515 → $580 | $530.84 | +9.26% | 2 | Jun 11, 2025 | |
| ELAN Elanco Animal Health | Initiates: Market Perform | $14 | $14.35 | -2.41% | 1 | Dec 2, 2024 | |
| ZTS Zoetis | Initiates: Outperform | $215 | $156.53 | +37.35% | 1 | Dec 2, 2024 |
IDEXX Laboratories
Jun 11, 2025
Maintains: Outperform
Price Target: $515 → $580
Current: $530.84
Upside: +9.26%
Elanco Animal Health
Dec 2, 2024
Initiates: Market Perform
Price Target: $14
Current: $14.35
Upside: -2.41%
Zoetis
Dec 2, 2024
Initiates: Outperform
Price Target: $215
Current: $156.53
Upside: +37.35%